2 NRTIs

DRUG2 trials

Sponsors

Pfizer, Merck Sharp & Dohme LLC

Conditions

HIV InfectionsHuman Immunodeficiency Virus (HIV) Infection

Phase 2

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

CompletedNCT00052117

PfizerHIV Infections

Start: 2003-01-31End: 2005-05-31Target: 300Updated: 2007-10-10

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

RecruitingNCT04375800

Merck Sharp & Dohme LLCHuman Immunodeficiency Virus (HIV) Infection

Start: 2021-02-03End: 2034-04-11Target: 84Updated: 2026-02-24